Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Evofem Biosciences, Inc. shareholders approved Approval of an amendment to the Company's Certificate of Incorporation to effectuate a reverse stock split of the outstanding shares of the Company's common stock by a ratio of not less than 1-for-20 and not more than 1-for-125 at any time on or prior to March 15, 2024, with the exact ratio to be se at the 2023-03-15 meeting.
- Proposal
- reverse split
- Outcome
- passed
- Meeting
- 2023-03-15
Exact text from the filing
Proposal No. 1: The Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation to effectuate a reverse stock split of the outstanding shares of the Company’s common stock by a ratio of not less than 1-for-20 and not more than 1-for-125 at any time on or prior to March 15, 2024, with the exact ratio to be set at a whole number within such range by the Company’s board of directors (the “Board”), at the sole discretion of the Board, as follows: Votes For Votes Against Abstentions Broker Non-Votes 132,595,045 23,270,478 1,693,299 0
View on SEC.gov